Home > Healthcare > Medical Devices > Diagnostic Devices > Bloodstream Infection Testing Market

Bloodstream Infection Testing Market Trends

Report ID: GMI7992
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Bloodstream Infection Testing Market Trends

The notable increase in healthcare-associated bloodstream infections (HA-BSI) in recent years serves as a driving factor for the market. The surge in cases, particularly attributed to the use of intravascular catheters, has raised significant concerns globally.

As per the World Health Organization (WHO), antimicrobial-resistant pathogens causing bloodstream infections has become the second leading cause of global burdens related to antimicrobial resistance (AMR), resulting in a substantial number of fatalities worldwide.
Healthcare-associated bloodstream infections (HA-BSI) rank second in Europe among healthcare-associated Infections (HAIs) in terms of frequency of disability and early mortality. These results underline the critical need for efficient interventions in the healthcare industry and demonstrate the substantial influence of HA-BSIs on patient outcomes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bloodstream infection testing industry was worth USD 875.1 million in revenue in 2023 and is estimated to exceed USD 1.33 billion by 2032 attributed to the rising prevalence of infectious diseases coupled with growing awareness and the increasing emphasis on infectious disease diagnosis.

Bloodstream infection testing industry size from the reagents and consumables segment garnered USD 737.1 million in 2023 and is projected to depict notable growth between 2024 and 2032 owing to the ongoing advancements in molecular and immunological reagents.

North America bloodstream infection testing industry size was USD 381.6 million in 2023 and is set to exhibit robust growth through 2032 driven by the increasing disposable incomes and favorable reimbursement policies in the region.

Some leading bloodstream infection testing industry players are Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., Luminex Corporation, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.